Kenya’s Pharmacy Board Secures Two African Medicines Agency Committee Seats

What changed

Kenya’s Pharmacy and Poisons Board has secured two seats on the African Medicines Agency’s technical committees, announced during the agency’s inaugural week in Kigali on November 6, 2026.

• Dr Ali Abdulahi Arale joined the committee evaluating medicines, vaccines and biologicals.
• Dr Edward Abwao joined the committee overseeing clinical trials and Good Clinical Practice, and was elected its chairperson.

Both appointments run for an initial two-year term.

Why it matters

The appointments give Kenyan regulators a direct role in the scientific work behind continent-wide medicines standards. The committees advise on medical products and clinical trials, helping support evidence-based decisions, shared regulatory standards and stronger national systems.

Abwao’s election as chair is the more significant development. It places a Kenyan regulator in charge of a committee dealing with clinical-trial oversight, an area where consistent rules matter because research and product approvals increasingly cross national borders.

The practical test will be what the committees do first. These appointments create influence and responsibility, but they do not by themselves show that medicines will reach patients faster or that approval times will fall.